JMI Syringes & Medical Devices Ltd. (JMISMDL)
A
| Pharmaceuticals & Chemicals
INTRADAY 1MIN CHART
Loading ...
Price: -
Volume: -
Today Analysis
JMI Syringes & Medical Devices Ltd. এর শেয়ারটি 126.30 BDT-এ লেনদেন হচ্ছে, যা বর্তমান ট্রেন্ডে পতনের দিকে। কোম্পানিটির NAV 87.23 BDT-এ অবস্থান করছে, যা দীর্ঘমেয়াদী বিনিয়োগের জন্য একটি নির্দেশক হিসেবে কাজ করে। কোম্পানির P/E Ratio নির্দেশ করে এটি তুলনামূলকভাবে আয়ের চেয়ে কতগুণ বেশি মূল্যে লেনদেন হচ্ছে। টেকনিক্যাল এনালাইসিস অনুযায়ী, সাপোর্ট লেভেল 122.51 BDT-এর কাছাকাছি হতে পারে, যেখানে শেয়ারটি ঘুরে দাঁড়াতে পারে। অন্যদিকে 130.72 BDT-এ একটি সম্ভাব্য রেজিস্ট্যান্স আছে, যেখানে দাম বাধা পেতে পারে। বিনিয়োগের সিদ্ধান্ত নেওয়ার আগে, মার্কেটের সামগ্রিক অবস্থা ও কোম্পানির ফান্ডামেন্টালগুলো বিবেচনা করা জরুরি।
(Disclaimer: This system generated summary is for informational purposes only and does not constitute financial advice.)
Market Depth (Live Order Book)
Buy Orders (Bids)
| Cum Qty | Volume | Price |
|---|---|---|
| No buy orders | ||
Sell Orders (Asks)
| Price | Volume | Cum Qty |
|---|---|---|
| No sell orders | ||
| Date | Close | Volume | Trade | Change | Ch(%) | Open | High | Low |
|---|---|---|---|---|---|---|---|---|
| Loading historical data... | ||||||||
23 Sep, 2026
JMISMDL: Change of Share Office Address
The company has informed that the Board of Directors in its Meeting held on September 22, 2026 has resolved to change the Share Office of the Company as follows: Old Address: Plot# 29/C & 29/D (2nd Floor), Tejgaon Industrial Area, Dhaka-1208, Bangladesh. New Address: House#430/1/A (4th Floor), Tejgaon Industrial Area, Dhaka-1208, Bangladesh. (cont.)
29 Apr, 2026
JMISMDL: Q3 Financials
(Q3 Un-audited): EPS was Tk. (2.39) for January-March 2026 as against Tk. (0.02) for January-March 2025; EPS was Tk. (2.89) for July 2025-March 2026 as against Tk. 1.68 for July 2024-March 2025. NOCFPS was Tk. 2.07 for July 2025-March 2026 as against Tk. 2.67 for July 2024-March 2025. NAV per share was Tk. 83.34 as on March 31, 2026 and Tk. 87.23 as on June 30, 2025. (cont.1)
16 Apr, 2026
JMISMDL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2026 at 2:35 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
28 Jan, 2026
JMISMDL: Q2 Financials
(Q2 Un-audited): EPS was Tk. (0.01) for October-December 2025 as against Tk. 0.98 for October-December 2024; EPS was Tk. (0.51) for July-December 2025 as against Tk. 1.71 for July-December 2024. NOCFPS was Tk. (0.63) for July-December 2025 as against Tk. 2.93 for July-December 2024. NAV per share was Tk. 85.72 as on December 31, 2025 and Tk. 87.23 as on June 30, 2025. Reasons for deviations: During the reported period Net profit after Tax and (cont.)
18 Jan, 2026
JMISMDL: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
14 Jan, 2026
JMISMDL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2026 at 2:35 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.
23 Dec, 2025
JMISMDL: Credit Rating Result
Alpha Credit Rating PLC. (Alpha Rating) has assigned surveillance rating of the Company as "AA" in the long term and "ST-1" in the short term along with Stable outlook based on audited financial statements as on June 30, 2025 and relevant qualitative information till December 21, 2025.
22 Dec, 2025
JMISMDL: Emphasis of Matter
The auditor of the company has given the Emphasis of Matter paragraph in the auditor's report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JMISMDL_2025.pdf
17 Nov, 2025
JMISMDL: Resumption after Record Date
Trading of the shares of the company will resume on 18.11.2025.
16 Nov, 2025
JMISMDL: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 17.11.2025.
16 Nov, 2025
JMISMDL: Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.50) for July-September 2025 as against Tk. 0.73 for July-September 2024. NOCFPS was Tk. (2.17) for July-September 2025 as against Tk. 1.05 for July-September 2024. NAV per share was Tk. 86.73 as on September 30, 2025 and Tk. 87.23 as on June 30, 2025. Reasons for deviation: During the reported period Net profit after Tax and EPS are decreased in comparison with previous period due to decrease of sales and increases of all type of expenses. (cont.)
12 Nov, 2025
JMISMDL: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 13.11.2025 to 16.11.2025 and trading of the shares will remain suspended on record date i.e., 17.11.2025.
03 Nov, 2025
JMISMDL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2025 at 2:35 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
28 Oct, 2025
JMISMDL: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (28.10.2025) following its corporate declaration.
28 Oct, 2025
JMISMDL: Dividend Declaration
The Board of Directors has recommended 10% Cash Dividend for the year ended June 30, 2025. Date of AGM: 23.12.2025; Time: 11:30 AM; Venue/Mode of AGM: Virtually by using Digital Platform. Link: https://jmismdl.bdvirtualagm.com. Record Date: 17.11.2025. The Company has also reported EPS of Tk. 1.49, NAV per share of Tk. 87.23 and NOCFPS of Tk. 3.57 for the year ended June 30, 2025 as against Tk. 1.29, Tk. 86.66 and Tk. 4.06 respectively for the year ended June 30, 2024.
19 Oct, 2025
JMISMDL: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2025 at 2:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
29 Apr, 2025
JMISMDL: Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.02) for January-March 2025 as against Tk. 0.36 for January-March 2024; EPS was Tk. 1.68 for July 2024-March 2025 as against Tk. 0.50 for July 2023-March 2024. NOCFPS was Tk. 2.67 for July 2024-March 2025 as against Tk. 3.38 for July 2023-March 2024. NAV per share was Tk. 87.44 as on March 31, 2025 and Tk. 86.66 as on June 30, 2024. Significant Deviation: EPS: During the reported period Sales, Net profit after Tax and Earning per Share (EPS) (cont.)
20 Apr, 2025
JMISMDL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2025 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
04 Mar, 2025
JMISMDL: Regarding revaluation of Property, Plant and Equipment of the company
The company has informed that the Board of Directors has approved the Revaluation of Property, Plant and Equipment (Land & Factory Buildings) based on December 31, 2024. To view the details, please visit: https://www.dsebd.org/Annexure/2024/JMISYRINGES_2024.pdf
30 Jan, 2025
JMISMDL: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.98 for October-December 2024 as against Tk. 0.07 for October-December 2023; EPS was Tk. 1.71 for July-December 2024 as against Tk. 0.15 for July-December 2023. NOCFPS was Tk. 2.93 for July-December 2024 as against Tk. 2.44 for July-December 2023. NAV per share was Tk. 87.37 as on December 31, 2024 and Tk. 86.66 as on June 30, 2024. (cont.1)
15 Jan, 2025
JMISMDL: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
12 Jan, 2025
JMISMDL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2025 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
01 Jan, 2025
JMISMDL: Credit Rating Result
Alpha Credit Rating Limited (Alpha Rating) has assigned the Surveillance rating of the Company as "AA-" in the long term and "ST-1" in the short term along with Stable outlook based on the audited financial statement up to June 30, 2024 and relevant qualitative information till December 30, 2024.
27 Nov, 2024
JMISMDL: Qualified Opinion
The auditor of the company has given the "Qualified Opinion" paragraphs in the Auditor's Report of the company for the year ended June 30, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/November/JMISMDL_2024.pdf
18 Nov, 2024
JMISMDL: Resumption after Record Date
Trading of the shares of the company will resume on 19.11.2024.
17 Nov, 2024
JMISMDL: Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 18.11.2024.
13 Nov, 2024
JMISMDL: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 14.11.2024 to 17.11.2024 and trading of the shares of the company will remain suspended on record date i.e., 18.11.2024.
13 Nov, 2024
JMISMDL: Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.73 for July-September 2024 as against Tk. 0.08 for July-September 2023; NOCFPS was Tk. 1.05 for July-September 2024 as against Tk. 1.22 for July-September 2023. NAV per share was Tk. 87.39 as on September 30, 2024 and Tk. 86.66 as on June 30, 2024. Reasons for deviation in EPS and NOCFPS: During the reported period Sales, Net profit after Tax and EPS are increased due to increase of sales price of the products and also trying to reduced expenses. (cont.1)
04 Nov, 2024
JMISMDL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2024 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
22 Oct, 2024
JMISMDL: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (22.10.2024) following its corporate declaration.
22 Oct, 2024
JMISMDL: Dividend Declaration
The Board of Directors has recommended 10% Cash dividend for the year ended June 30, 2024. Date of AGM: 23.12.2024, Time: 11:30 AM, Venue: Digital Platform at https://jmismdl.bdvirtualagm.com. Record Date: 18.11.2024. The Company has also reported EPS of Tk. 1.29, NAV per share of Tk. 86.66 and NOCFPS of Tk. 4.06 for the year ended June 30, 2024 as against Tk. (4.99), Tk. 86.37 and Tk. 2.19 respectively for the year ended June 30, 2023.
07 Oct, 2024
JMISMDL: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 21, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
Total Records: 11 Years
| Year | Type | Cash(%) | Stock(%) | EPS | NAV | Remarks |
|---|---|---|---|---|---|---|
| 2025 | Final | 10.00% | - | 1.49 | 87.23 | 28-Oct-2025 |
| 2024 | Final | 10.00% | - | 1.29 | 86.66 | 22-Oct-2024 |
| 2023 | Final | 10.00% | - | -4.99 | 86.37 | 31-Oct-2023 |
| 2022 | Final | - | 36.00% | 4.55 | 124.25 | 18-Oct-2022 |
| 2021 | Final | 30.00% | - | 4.03 | 122.70 | 28-Oct-2021 |
| 2020 | Annual | 30.00% | - | 4.35 | 121.66 | 28-Oct-2020 |
| 2019 | Annual | 30.00% | - | 6.05 | 68.74 | 22-Sep-2019 |
| 2018 | Annual | 30.00% | - | 6.86 | 71.27 | - |
| 2017 | Annual | 30.00% | - | 6.78 | 67.64 | - |
| 2016 | Annual | 35.00% | - | 4.07 | 64.63 | - |
| 2014 | Annual | 20.00% | - | 4.46 | 48.86 | - |
30-Day Block Transactions
| Date | Max Price | Min Price | Trades | Quantity | Value (Mn) |
|---|---|---|---|---|---|
| No block transactions in the last 30 days. | |||||
Company Info
Trading Code
JMISMDL
Category : Sector
A : Pharmaceuticals & Chemicals
NAV
87.23 Tk.
P/E Audited
87.25
Paid up Capital
300.56 crore
Authorized Capital
1,000.00 crore
Market Capital
3,850.17 crore
Total Securities
30,056,000
Reserve & Surplus
249.41 crore
Website
http://www.jmisyringe.com
Current Shareholding
Public Holding: 0.44 Cr unit
Public: 14.50% (0.44 Cr unit)
Director: 79.65% (2.39 Cr unit)
Institute: 5.85% (0.18 Cr unit)
Foreign: 0.00% (0.00 Cr unit)
Govt: 0.00% (0.00 Cr unit)
EPS History
NAV History
Dividend History
Cash Dividend
Stock Dividend
Historical Monthly Performance
Compare cumulative monthly performance.
Best Month
-
Worst Month
-
Avg MoM
-
Positive
-
Positive Yrs
-
Historical Insight
-
Historical Seasonality
Holding Period Returns
Entry → Exit Analysis
Entry Month:
Select an entry month to view historical holding period outcomes.
* Historical performance is not indicative of future results. Historical calculations are based on past closing prices and do not constitute investment advice. Dividends are not included.
| Period Ending: |
2021
07/10/2026
|
2022
07/10/2026
|
2023
07/10/2026
|
2024
07/10/2026
|
2025
07/10/2026
|
|---|---|---|---|---|---|
| Total Revenues | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Gross Profit | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Operating Expenses | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Operating Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Pre-tax Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Net Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| EBITDA | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| EPS (Basic) | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash & Equivalents | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Current Assets | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Assets | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Current Liabilities | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Liabilities | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Debt | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Equity | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Operations | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Investing | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Financing | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Capital Expenditure | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Free Cash Flow | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Net Change in Cash | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
Unlock Full Financial Data
Upgrade to PRO to access complete historical financial statements, quarterly reports, and deep fundamental analysis.
Upgrade to PROJMI Syringes & Medical Devices Ltd.
A | Pharmaceuticals & Chemicals
Today-
15 dys-
30 dys-
3 mths-
6 mths-
1 yr-
LTP:-
Open:-
High:-
Low:-
YCP:-
Vol:-
52W H:-
52W L:-
Crct Lw:-
Circuit Up:-
Value:-
M. Cap:-
P/E (Un/A):-
EPS:-
NAV:-
Paid-up:-
Ttl Share:-
Yr end:-
Reserve:-
ROE:-
EPS Q2-
EPS Q3-
EPS ANN-
EPS Q1-
DIV-
DIV YIELD-
Last AGM: -
Record Date: -
Shareholding
(as on -)
Public
0%
Director
0%
Institute
0%
Foreign
0%
Govt.
0%
Market Overview
Loading Data...
(%)
Day Open
Total Trade
Day High
Total Volume
Day Low
Value (Cr)
MARKET STATUS
Up
Down
Unchanged
All Instruments
| Symbol | LTP | Chg% |
|---|---|---|
| Loading... | ||
Sectors
| Sector | Chg% |
|---|---|
| Loading... | |
Stock Screener
Quick Screens
| Symbol | LTP | PE |
|---|---|---|
| Run filter to see results | ||
Alerts
Favorites
Watchlists
Portfolio
My Screeners
| Symbol | LTP | PE |
|---|
Run filter to see results
Market Movers
| # | Symbol | LTP | Chg% |
|---|---|---|---|
| Loading... | |||
AI Insights
Business Pro user exclusive
Login to see